Industry: Chemical & Material
Published Date: 2024-04-15
Pages: 110 Pages
Report ld: 2831710
Request Sample
Customized Report
The global Febantel market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Febantel is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Febantel is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Febantel is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Febantel include Pure Chemistry Scientific, LGM Pharma, BOC Sciences, TCI, HBCChem, Toronto Research Chemicals, Texas Biochemicals, Waterstone Technology and 2A PharmaChem, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Febantel production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Febantel by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Covers:
This report presents an overview of global market for Febantel, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Febantel, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Febantel, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Febantel sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Febantel market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Febantel sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Febantel production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Febantel in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Febantel manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Febantel sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Febantel Product Introduction
1.2 Market by Type
1.2.1 Global Febantel Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Purity 98%
1.2.3 Purity 99%
1.2.4 Others
1.3 Market by Application
1.3.1 Global Febantel Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Chemical Reagents
1.3.3 Pharmaceutical Intermediates
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Febantel Production
2.1 Global Febantel Production Capacity (2019-2030)
2.2 Global Febantel Production by Region: 2019 VS 2023 VS 2030
2.3 Global Febantel Production by Region
2.3.1 Global Febantel Historic Production by Region (2019-2024)
2.3.2 Global Febantel Forecasted Production by Region (2025-2030)
2.3.3 Global Febantel Production Market Share by Region (2019-2030)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Febantel Revenue Estimates and Forecasts 2019-2030
3.2 Global Febantel Revenue by Region
3.2.1 Global Febantel Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Febantel Revenue by Region (2019-2024)
3.2.3 Global Febantel Revenue by Region (2025-2030)
3.2.4 Global Febantel Revenue Market Share by Region (2019-2030)
3.3 Global Febantel Sales Estimates and Forecasts 2019-2030
3.4 Global Febantel Sales by Region
3.4.1 Global Febantel Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Febantel Sales by Region (2019-2024)
3.4.3 Global Febantel Sales by Region (2025-2030)
3.4.4 Global Febantel Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Febantel Sales by Manufacturers
4.1.1 Global Febantel Sales by Manufacturers (2019-2024)
4.1.2 Global Febantel Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Febantel in 2023
4.2 Global Febantel Revenue by Manufacturers
4.2.1 Global Febantel Revenue by Manufacturers (2019-2024)
4.2.2 Global Febantel Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Febantel Revenue in 2023
4.3 Global Febantel Sales Price by Manufacturers
4.4 Global Key Players of Febantel, Industry Ranking, 2022 VS 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Febantel Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Febantel, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Febantel, Product Offered and Application
4.8 Global Key Manufacturers of Febantel, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Febantel Sales by Type
5.1.1 Global Febantel Historical Sales by Type (2019-2024)
5.1.2 Global Febantel Forecasted Sales by Type (2025-2030)
5.1.3 Global Febantel Sales Market Share by Type (2019-2030)
5.2 Global Febantel Revenue by Type
5.2.1 Global Febantel Historical Revenue by Type (2019-2024)
5.2.2 Global Febantel Forecasted Revenue by Type (2025-2030)
5.2.3 Global Febantel Revenue Market Share by Type (2019-2030)
5.3 Global Febantel Price by Type
5.3.1 Global Febantel Price by Type (2019-2024)
5.3.2 Global Febantel Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Febantel Sales by Application
6.1.1 Global Febantel Historical Sales by Application (2019-2024)
6.1.2 Global Febantel Forecasted Sales by Application (2025-2030)
6.1.3 Global Febantel Sales Market Share by Application (2019-2030)
6.2 Global Febantel Revenue by Application
6.2.1 Global Febantel Historical Revenue by Application (2019-2024)
6.2.2 Global Febantel Forecasted Revenue by Application (2025-2030)
6.2.3 Global Febantel Revenue Market Share by Application (2019-2030)
6.3 Global Febantel Price by Application
6.3.1 Global Febantel Price by Application (2019-2024)
6.3.2 Global Febantel Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Febantel Market Size by Type
7.1.1 US & Canada Febantel Sales by Type (2019-2030)
7.1.2 US & Canada Febantel Revenue by Type (2019-2030)
7.2 US & Canada Febantel Market Size by Application
7.2.1 US & Canada Febantel Sales by Application (2019-2030)
7.2.2 US & Canada Febantel Revenue by Application (2019-2030)
7.3 US & Canada Febantel Sales by Country
7.3.1 US & Canada Febantel Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Febantel Sales by Country (2019-2030)
7.3.3 US & Canada Febantel Revenue by Country (2019-2030)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Febantel Market Size by Type
8.1.1 Europe Febantel Sales by Type (2019-2030)
8.1.2 Europe Febantel Revenue by Type (2019-2030)
8.2 Europe Febantel Market Size by Application
8.2.1 Europe Febantel Sales by Application (2019-2030)
8.2.2 Europe Febantel Revenue by Application (2019-2030)
8.3 Europe Febantel Sales by Country
8.3.1 Europe Febantel Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Febantel Sales by Country (2019-2030)
8.3.3 Europe Febantel Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Febantel Market Size by Type
9.1.1 China Febantel Sales by Type (2019-2030)
9.1.2 China Febantel Revenue by Type (2019-2030)
9.2 China Febantel Market Size by Application
9.2.1 China Febantel Sales by Application (2019-2030)
9.2.2 China Febantel Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Febantel Market Size by Type
10.1.1 Asia Febantel Sales by Type (2019-2030)
10.1.2 Asia Febantel Revenue by Type (2019-2030)
10.2 Asia Febantel Market Size by Application
10.2.1 Asia Febantel Sales by Application (2019-2030)
10.2.2 Asia Febantel Revenue by Application (2019-2030)
10.3 Asia Febantel Sales by Region
10.3.1 Asia Febantel Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Febantel Revenue by Region (2019-2030)
10.3.3 Asia Febantel Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Febantel Market Size by Type
11.1.1 Middle East, Africa and Latin America Febantel Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Febantel Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Febantel Market Size by Application
11.2.1 Middle East, Africa and Latin America Febantel Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Febantel Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Febantel Sales by Country
11.3.1 Middle East, Africa and Latin America Febantel Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Febantel Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Febantel Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Pure Chemistry Scientific
12.1.1 Pure Chemistry Scientific Company Information
12.1.2 Pure Chemistry Scientific Overview
12.1.3 Pure Chemistry Scientific Febantel Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 Pure Chemistry Scientific Febantel Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Pure Chemistry Scientific Recent Developments
12.2 LGM Pharma
12.2.1 LGM Pharma Company Information
12.2.2 LGM Pharma Overview
12.2.3 LGM Pharma Febantel Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 LGM Pharma Febantel Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 LGM Pharma Recent Developments
12.3 BOC Sciences
12.3.1 BOC Sciences Company Information
12.3.2 BOC Sciences Overview
12.3.3 BOC Sciences Febantel Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 BOC Sciences Febantel Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 BOC Sciences Recent Developments
12.4 TCI
12.4.1 TCI Company Information
12.4.2 TCI Overview
12.4.3 TCI Febantel Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 TCI Febantel Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 TCI Recent Developments
12.5 HBCChem
12.5.1 HBCChem Company Information
12.5.2 HBCChem Overview
12.5.3 HBCChem Febantel Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.5.4 HBCChem Febantel Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 HBCChem Recent Developments
12.6 Toronto Research Chemicals
12.6.1 Toronto Research Chemicals Company Information
12.6.2 Toronto Research Chemicals Overview
12.6.3 Toronto Research Chemicals Febantel Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.6.4 Toronto Research Chemicals Febantel Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Toronto Research Chemicals Recent Developments
12.7 Texas Biochemicals
12.7.1 Texas Biochemicals Company Information
12.7.2 Texas Biochemicals Overview
12.7.3 Texas Biochemicals Febantel Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.7.4 Texas Biochemicals Febantel Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Texas Biochemicals Recent Developments
12.8 Waterstone Technology
12.8.1 Waterstone Technology Company Information
12.8.2 Waterstone Technology Overview
12.8.3 Waterstone Technology Febantel Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.8.4 Waterstone Technology Febantel Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Waterstone Technology Recent Developments
12.9 2A PharmaChem
12.9.1 2A PharmaChem Company Information
12.9.2 2A PharmaChem Overview
12.9.3 2A PharmaChem Febantel Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.9.4 2A PharmaChem Febantel Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 2A PharmaChem Recent Developments
12.10 3B Scientific
12.10.1 3B Scientific Company Information
12.10.2 3B Scientific Overview
12.10.3 3B Scientific Febantel Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.10.4 3B Scientific Febantel Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 3B Scientific Recent Developments
12.11 J & K SCIENTIFIC
12.11.1 J & K SCIENTIFIC Company Information
12.11.2 J & K SCIENTIFIC Overview
12.11.3 J & K SCIENTIFIC Febantel Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.11.4 J & K SCIENTIFIC Febantel Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 J & K SCIENTIFIC Recent Developments
12.12 XiaoGan ShenYuan ChemPharm
12.12.1 XiaoGan ShenYuan ChemPharm Company Information
12.12.2 XiaoGan ShenYuan ChemPharm Overview
12.12.3 XiaoGan ShenYuan ChemPharm Febantel Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.12.4 XiaoGan ShenYuan ChemPharm Febantel Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 XiaoGan ShenYuan ChemPharm Recent Developments
12.13 Wuhan Fortuna Chemical
12.13.1 Wuhan Fortuna Chemical Company Information
12.13.2 Wuhan Fortuna Chemical Overview
12.13.3 Wuhan Fortuna Chemical Febantel Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.13.4 Wuhan Fortuna Chemical Febantel Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Wuhan Fortuna Chemical Recent Developments
12.14 Shanghai Haoyuan Chemexpress
12.14.1 Shanghai Haoyuan Chemexpress Company Information
12.14.2 Shanghai Haoyuan Chemexpress Overview
12.14.3 Shanghai Haoyuan Chemexpress Febantel Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.14.4 Shanghai Haoyuan Chemexpress Febantel Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Shanghai Haoyuan Chemexpress Recent Developments
12.15 Shanghai Aladdin Bio-Chem Technology
12.15.1 Shanghai Aladdin Bio-Chem Technology Company Information
12.15.2 Shanghai Aladdin Bio-Chem Technology Overview
12.15.3 Shanghai Aladdin Bio-Chem Technology Febantel Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.15.4 Shanghai Aladdin Bio-Chem Technology Febantel Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Shanghai Aladdin Bio-Chem Technology Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Febantel Industry Chain Analysis
13.2 Febantel Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Febantel Production Mode & Process
13.4 Febantel Sales and Marketing
13.4.1 Febantel Sales Channels
13.4.2 Febantel Distributors
13.5 Febantel Customers
14 Febantel Market Dynamics
14.1 Febantel Industry Trends
14.2 Febantel Market Drivers
14.3 Febantel Market Challenges
14.4 Febantel Market Restraints
15 Key Finding in The Global Febantel Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Febantel was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 136
USD 3950.00
(Single User License)
The global Febantel market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 138
USD 2900.00
(Single User License)
The global Febantel market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 153
USD 4900.00
(Single User License)
The global Febantel market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 100
USD 4250.00
(Single User License)
The global market for Febantel was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 120
USD 3950.00
(Single User License)
The global market for Febantel was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 104
USD 2900.00
(Single User License)
The global market for Febantel was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 136
USD 3950.00
(Single User License)
The global Febantel market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 113
USD 2900.00
(Single User License)
The global market for Febantel was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 136
The global Febantel market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 138
The global Febantel market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 153
The global Febantel market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 100
The global market for Febantel was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 120
The global market for Febantel was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 104
The global market for Febantel was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 136
The global Febantel market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 113
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now